Background: Late preterm infants show a major fat mass accretion from birth to term. The contribution of preterm birth to the development of the metabolic syndrome is still under investigation. Objectives: To evaluate body composition changes in late preterm infants during the first 3 months and to investigate their insulin sensitivity and resistance. Methods: We conducted an observational, longitudinal study. A total of 216 late preterm infants underwent body composition assessment using an air displacement plethysmograph at term and at 3 months of corrected age. In a subgroup of infants (n = 48) the blood glucose and insulin concentration were determined at term and insulin resistance (homeostasis model assessment for insulin resistance; HOMA-IR) and sensitivity (quantitative insulin sensitivity check index; QUICKI) were then calculated. The reference group comprised 71 healthy term infants. Results: The mean birth weight and gestational age were 2,390 ± 391 g and 35.2 ± 0.8 weeks, respectively. At term the fat mass index (kg/m2) of late preterm infants, born adequate for their gestational age and small for their gestational age, was higher than that of term infants (2.08 ± 0.82 vs. 1.62 ± 0.64 vs. 1.03 ± 0.36, p < 0.005, respectively), whereas at 3 months of corrected age no difference was found among the groups. The mean values of glucose, insulin, HOMA-IR, and QUICKI were within the 5th and 95th percentiles. Conclusions: On the basis of these preliminary findings, fat mass accretion of late preterm infants appears not to be associated with perturbation of the glucose homeostasis.

Keywords:
Late preterm infants, Insulin, Fat mass
1.
Sutton EF, Gilmore LA, Dunger DB, Heijmans BT, Hivert MF, Ling C, Martinez JA, Ozanne SE, Simmons RA, Szyf M, Waterland RA, Redman LM, Ravussin E: Developmental programming: state-of-the-science and future directions - summary from a Pennington Biomedical Symposium. Obesity 2016;24:1018-1026.
2.
Koletzko B, Brands B, Chourdakis M, Cramer S, Grote V, Hellmuth C, Kirchberg F, Prell C, Rzehak P, Uhl O, Weber M: The Power of Programming and the EarlyNutrition Project: opportunities for health promotion by nutrition during the first thousand days of life and beyond. Ann Nutr Metab 2014;64:187-196.
3.
Giannì ML, Roggero P, Liotto N, Amato O, Piemontese P, Morniroli D, Bracco B, Mosca F: Postnatal catch-up fat after late preterm birth. Pediatr Res 2012;72:637-640.
4.
Giannì ML, Roggero P, Liotto N, Taroni F, Polimeni A, Morlacchi L, Piemontese P, Consonni D, Mosca F: Body composition in late preterm infants according to percentile at birth. Pediatr Res 2016;79:710-775.
5.
De Cunto A, Paviotti G, Demarini S: When does postnatal catch-up fat occur in late preterm infants? Acta Paediatr 2014;103:e325.
6.
Olhager E, Törnqvist C: Body composition in late preterm infants in the first 10 days of life and at full term. Acta Paediatr 2014;103:737-743.
7.
Aly H, Soliman RM, El-Dib M, Fawzy EM, Badawi NE, Rabie WA, Elbadawi AA: Birth weight, insulin resistance, and blood pressure in late preterm infants. Am J Perinatol 2015;32:865-872.
8.
Wang G, Divall S, Radovick S, Paige D, Ning Y, Chen Z, Ji Y, Hong X, Walker SO, Caruso D, Pearson C, Wang MC, Zuckerman B, Cheng TL, Wang X: Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA 2014;311:587-596.
9.
Giannì ML, Roggero P, Piemontese P, Liotto N, Orsi A, Amato O, Taroni F, Morlacchi L, Consonni D, Mosca F: Is nutritional support needed in late preterm infants? BMC Pediatr 2015;15:194.
10.
Fenton TR, Kim JH: A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr 2013;13:59.
11.
Agostoni C, Grandi F, Scaglioni S, Giannì ML, Torcoletti M, Radaelli G, Fiocchi A, Riva E: Growth pattern of breastfed and non breastfed infants with atopic dermatitis in the first year of life. Pediatrics 2000;106:E73.
12.
Roggero P, Giannì ML, Amato O, Piemontese P, Morniroli D, Wong WW, Mosca F: Evaluation of air-displacement plethysmography for body composition assessment in preterm infants. Pediatr Res 2012;72:316-320.
13.
Urlando A, Dempster P, Aitkens S: A new air displacement plethysmograph for the measurement of body composition in infants. Pediatr Res 2003;53:486-492.
14.
Gesteiro E, Bastida S, Sánchez-Muniz FJ: Insulin resistance markers in term, normoweight neonates: the Mérida cohort. Eur J Pediatr 2009;168:281-288.
15.
Roggero P, Giannì ML, Liotto N, Taroni F, Orsi A, Amato O, Morlacchi L, Piemontese P, Agosti M, Mosca F: Rapid recovery of fat mass in small for gestational age preterm infants after term. PLoS One 2011;6:e14489.
16.
Sauer PJ: Can extrauterine growth approximate intrauterine growth? Should it? Am J Clin Nutr 2007;85:608S-613S.
17.
Uthaya S, Thomas EL, Hamilton G, Doré CJ, Bell J, Modi N: Altered adiposity after extremely preterm birth. Pediatr Res 2005;57:211-215.
18.
Pak K, Lee SH, Lee JG, Seok JW, Kim IJ: Comparison of visceral fat measures with cardiometabolic risk factors in healthy adults. PLoS One 2016;11:e0153031.
19.
Roggero P, Giannì ML, Forzenigo L, Tondolo T, Taroni F, Liotto N, Piemontese P, Biondetti P, Mosca F: No relative increase in intra-abdominal adipose tissue in healthy unstressed preterm infants at term. Neonatology 2015;107:14-19.
20.
Hay WW, Brown LD, Denne SC: Energy requirements, protein-energy metabolism and balance, and carbohydrates in preterm infants. World Rev Nutr Diet 2014;110:64-81.
21.
Vasu V, Modi N: Assessing the impact of preterm nutrition. Early Hum Dev 2007;83:813-818.
22.
Bagnoli F, Vodo F, Vodo S, Conte ML, Tomasini B, Vodo Z, Pasqui L, Sestini F: Glucagon and insulin cord blood levels in very preterm, late preterm and full-term infants. J Pediatr Endocrinol Metab 2014;27:419-423.
23.
Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, Cutfield WS: Premature birth and later insulin resistance. N Engl J Med 2004;351:2179-2186.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.